Research breakthroughs, partnerships, conference appearances, and company milestones — stay up to date with everything happening at Quadralynx.
The 2025 AgeTech market overview highlights accelerating adoption of AI-powered remote monitoring, fall detection, and telehealth tools among older adults — with wearables and voice assistants emerging as the most rapidly growing categories for aging-in-place support.
A new analysis of AI applications in home care finds that conversational AI, predictive health monitoring, and automated medication reminders are reducing caregiver workload and improving safety outcomes for older adults living independently.
Care partners of people with Parkinson's disease face elevated rates of emotional exhaustion, social isolation, and physical strain as the disease progresses. The Parkinson's Foundation outlines warning signs of caregiver burnout and practical strategies for protecting caregiver health.
As Parkinson's disease advances, many care partners reach a point where additional professional support becomes necessary. This resource from the Parkinson's Foundation helps families identify the right time to bring in outside help and how to prepare for that transition.
Managing the financial and legal dimensions of a Parkinson's diagnosis — from disability benefits and insurance coverage to estate planning and power of attorney — presents significant challenges for patients and their families. This overview from the Parkinson's Foundation covers key considerations at every stage.
A 12-month randomized controlled trial found that home-based stationary cycling at high cadence (≥75 RPM) significantly slowed motor symptom progression in people with mild-to-moderate Parkinson's disease, with 93% adherence — suggesting structured aerobic exercise may be a viable disease-modifying intervention.
A well-coordinated care team is one of the most important factors in managing Parkinson's disease effectively. The Michael J. Fox Foundation explains the roles of neurologists, movement disorder specialists, physical therapists, and other key members — and how to build a team that fits your needs.
Two Phase 1/2a trials presented at the MDS International Congress reported that dopaminergic stem cell transplantation was safe and showed dose-dependent motor improvements in Parkinson's patients, with higher-dose groups showing the most benefit and no serious adverse events.
Regulators cleared a focused ultrasound procedure capable of addressing motor symptoms on both sides of the body — expanding on earlier single-side approvals and representing a meaningful step forward for patients managing bilateral tremor and rigidity.
In a ground-breaking study using tone-frequency discrimination tasks with mice in the context of perceptual decision-making, researchers found that both tone frequency and duration are critical factors.
The impacts to both familiar and professional caregivers providing care to people with Parkinson's disease and others suffering from neurological diseases and disorders continue to grow.
Representatives from Quadralynx attended the 2024 Flywheel Conference, connecting with innovators and investors driving the future of health technology in the Pacific Northwest.
Quadralynx scientists have convened with leading professors and research scientists at the Universities of Idaho, Washington State, Gonzaga, and Arizona State to advance our shared research goals.
R&D engineers from Quadralynx attended the WEAR Conference at the Marriott Marquis in San Diego in December 2023, meeting with leading wearable technology researchers and developers.
We attended the premier wearables conference this year. The annual WEAR Conference examines significant breakthroughs and new opportunities in wearable technology.
To develop software best suitable for our target customers — adults with Parkinson's disease — we have partnered with several firms specializing in accessible web application development.
Butler Technologies, a premier engineering and design-driven manufacturer of printed electronics and wearable biometric sensors, has agreed to partner with Quadralynx to develop our next-generation wearable platform.
Europe's premier Parkinson's disease support organization, Parkinson's Europe, supports Quadralynx's development of technologies and services for those suffering from PD.
Quadralynx's first patent, initially published and assigned to Washington State University, has been formally assigned to Quadralynx — a significant milestone for the company.
We are very fortunate to have Dr. Subhanshu Gupta join Quadralynx to help develop some of our novel technologies. An Associate Professor at WSU, Dr. Gupta brings deep expertise in electrical engineering.
We won! Quadralynx has been notified that we have won an NSF Phase I Small Business Innovation Research (SBIR) award — a major validation of our technology and mission.